MedBright AI Investments Inc. announced that the Dermatology Institute & Skin Care Center (?DISCC?), a leader in dermatologic services in Southern California, has chosen to implement MedMatrix to improve their clinic operations. MedMatrix is an industry leading AI-powered data analytics platform developed and operated by Healthcare Accretion AI, a Medbright AI investment. MedMatrix harnesses the power of artificial intelligence to evaluate and analyze key aspects of healthcare facilities, including patient needs and resource matching, revenue cycle management, patient demographics, facility geography, and competition.

Through its advanced AI and data analytics capabilities, MedMatrix works alongside healthcare professionals to optimize each of these critical areas, resulting in more efficient clinic operations and improved patient outcomes. DISCC specializes in cosmetic, medical, and surgical dermatology in Los Angeles. Led by board-certified dermatologist Paul Yamauchi, MD, PhD, the practice offers dermatology services to provide the highest quality skin care possible.

Dr. Yamauchi is a nationally recognized dermatologist and a key opinion leader in the subject of psoriatic, atopic dermatitis and other inflammatory skin disorders. In addition to his role as medical director for DISCC, he is also the medical director for Clinical Science Institute, the clinical assistant professor of dermatology for the David Geffen School of Medicine and an adjunct associate professor of the John Wayne Cancer Institute.